Abstract
Dengue is an infectious disease caused by one of the four serotypes of the dengue virus. It is a mosquito borne disease and the female Aedes mosquito is mainly spread to humans. The disease exists mostly in tropical and subtropical areas, placing about a third of the human population at risk of infection worldwide. The tremendous variety and the minimal similarity in identity at the level of amino acids contribute to a troublesome obstacle in the production of an effective vaccine. Vaccine production has been oriented towards the rational design of the epitope based vaccine through available immunological evidence, the advancement of the antigenic peptide prediction method, and the integration of molecular docking into immunoinformatics. So we are discovering new prevention steps, using immunoinformatics methods to create dengue epitope based subunit vaccine that can produce different immune responses inside the host. For structural and non-structural dengue virus proteins, distinct B and T cell binding epitopes were expected. Microscopic interactions between the epitope and the allele were confirmed by molecular docking. In this work epitopes KRSGIQEVD, RRDLRLAAN, RRGDLPVWL, FQIYKRSGI and THSSAAQRRGRIGRNP were predicted as a new immunotherapeutic agent for dengue vaccine that can provide prevention and control of outbreaks.
Similar content being viewed by others
References
Ali M, Pandey RK, Khatoon N, Narula A, Mishra A, Prajapati VK (2017) Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection. Sci Rep 7:9232
Bui HH, Sidney J, Li W, Fusseder N, Sette A (2007) Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinform 8(1):361
Centers for Disease Control and Prevention. CDC 2020. https://www.ecdc.europa.eu/en/dengue-monthly
Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform 8:4. https://doi.org/10.1186/1471-2105-8-4
Gopala Reddy SB, Chin WX, Shivananju NS (2018) Dengue virus NS2 and NS4: minor proteins, mammoth roles. Biochem Pharmacol 154(March):54–63. https://doi.org/10.1016/j.bcp.2018.04.008
Gupta S et al (2013) In silico approach for predicting toxicity of peptides andproteins. PLoS ONE 8:e73957. https://doi.org/10.1371/journal.pone.0073957
Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ et al (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8(12 Suppl):S7–S16. https://doi.org/10.1038/nrmicro2460
Kamthania M, Srivastava S, Desai M, Jain A, Shrivastav A, Sharma DK (2019) Immunoinformatics approach to design T-cell epitope-based vaccine against hendra virus. Int J Pept Res Ther 25(4):1627–1637
Kuhn RJ et al (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717–725. https://doi.org/10.1016/S0092-8674(02)00660-8
Osatomi K, Sumiyoshi H (1990) Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology 176:643–647. https://doi.org/10.1016/0042-6822(90)90037-R
Oyarzún P, Kobe B (2016) Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production. Hum Vaccin Immunother 12(3):763–767. https://doi.org/10.1080/21645515.2015.1094595
Saha S, Raghava GP (2006) AlgPred: prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res 34:W202–W209. https://doi.org/10.1093/nar/gkl343
Scaturro P, Cortese M, Chatel-Chaix L, Fischl W, Bartenschlager R (2015) Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins. PLoS Pathog 11:e1005277. https://doi.org/10.1371/journal.ppat.1005277
Singh H, Raghava GPS (2003) Propred I: prediction of HLA class I bindingsites. Bioinformatics 19:1009–1014. https://doi.org/10.1093/bioinformatics/btg108
Souza LJ, Pessanha LB, Mansur LC, Souza LA, Ribeiro MB, Silveira MDV, Souto Filho JT (2013) Comparison of clinical and laboratory characteristics between children and adults with dengue. Braz J Infect 17(1):27–31. https://doi.org/10.1016/j.bjid.2012.08.020
Tong JC, Ren EC (2009) Immunoinformatics: current trends and future directions. Drug Discov Today 14(13–14):684–689. https://doi.org/10.1016/j.drudis.2009.04.001
Tsai CY, Lee IK, Lee CH, Yang KD, Liu JW (2013) Comparisons of dengue illness classified based on the 1997 and 2009 World Health Organization dengue classification schemes. J Microbiol Immunol Infect 46(4):271–281. https://doi.org/10.1016/j.jmii.2012.07.005
Westaway EG, Brinton MA, Gaidamovich SYA, Horzinek MC, Igarashi A, Kääriäinen L et al (1985) Flaviviridae. Intervirology 24(4):183–192. https://doi.org/10.1159/000149642
World Health Organization (2016) Mosquito-borne diseases
Xie X, Zou J, Puttikhunt C, Yuan Z, Shi P-Y (2015) Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly. J Virol 89:1298–1313. https://doi.org/10.1128/jvi.02882-14
Yu I-M et al (2008) Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319:1834–1837. https://doi.org/10.1126/science.1153264
Yusof R, Clum S, Wetzel M, Murthy HK, Padmanabhan R (2000) Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem 275(14):9963–9969. https://doi.org/10.1074/jbc.275.14.9963
Zhou Y et al (2007) Structure and function of flavivirus NS5 methyltransferase. J Virol 81:3891–3903. https://doi.org/10.1128/jvi.02704-06
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dixit, N.K., Kumar, A. Design of Epitope Based Vaccine for Dengue Virus Using Immunoinformatic Approach. Int J Pept Res Ther 27, 1385–1396 (2021). https://doi.org/10.1007/s10989-021-10176-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-021-10176-1